 John Koeppe
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 11 | 2014 | 3148 | 0.760 |
Why?
| | Pain | 3 | 2013 | 785 | 0.710 |
Why?
| | Analgesics | 2 | 2012 | 232 | 0.600 |
Why?
| | Analgesics, Opioid | 2 | 2013 | 1142 | 0.380 |
Why?
| | Antiretroviral Therapy, Highly Active | 3 | 2012 | 278 | 0.360 |
Why?
| | Tuberculosis, Lymph Node | 1 | 2010 | 7 | 0.320 |
Why?
| | Mycobacterium avium Complex | 1 | 2010 | 88 | 0.300 |
Why?
| | Viral Proteins | 2 | 2011 | 353 | 0.260 |
Why?
| | HIV-1 | 3 | 2014 | 897 | 0.260 |
Why?
| | HIV Core Protein p24 | 2 | 2006 | 32 | 0.250 |
Why?
| | Chronic Pain | 1 | 2012 | 290 | 0.250 |
Why?
| | Interferon-gamma | 2 | 2010 | 781 | 0.250 |
Why?
| | Delivery of Health Care | 1 | 2013 | 944 | 0.240 |
Why?
| | HIV Antigens | 1 | 2006 | 17 | 0.240 |
Why?
| | Gene Products, gag | 1 | 2006 | 38 | 0.230 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2006 | 175 | 0.230 |
Why?
| | Viremia | 1 | 2006 | 159 | 0.220 |
Why?
| | Mycobacterium avium | 1 | 2004 | 21 | 0.200 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2004 | 19 | 0.200 |
Why?
| | Multivariate Analysis | 3 | 2013 | 1537 | 0.200 |
Why?
| | Peritonitis | 1 | 2004 | 83 | 0.190 |
Why?
| | Hospitalization | 1 | 2013 | 2446 | 0.190 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2004 | 63 | 0.190 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2006 | 1129 | 0.190 |
Why?
| | Emergency Service, Hospital | 1 | 2013 | 2325 | 0.170 |
Why?
| | Pain Measurement | 2 | 2012 | 554 | 0.140 |
Why?
| | Middle Aged | 12 | 2014 | 35971 | 0.130 |
Why?
| | CD4 Lymphocyte Count | 2 | 2011 | 277 | 0.100 |
Why?
| | Adult | 8 | 2014 | 40489 | 0.090 |
Why?
| | Drug Therapy, Combination | 2 | 2006 | 1044 | 0.090 |
Why?
| | Movement | 1 | 2014 | 295 | 0.090 |
Why?
| | Viral Load | 2 | 2011 | 528 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2006 | 2573 | 0.090 |
Why?
| | Male | 10 | 2014 | 72431 | 0.090 |
Why?
| | Interleukin-12 | 1 | 2010 | 117 | 0.080 |
Why?
| | Female | 9 | 2013 | 78304 | 0.080 |
Why?
| | Odds Ratio | 1 | 2012 | 1076 | 0.070 |
Why?
| | Severity of Illness Index | 2 | 2010 | 2922 | 0.070 |
Why?
| | Chronic Disease | 3 | 2010 | 1810 | 0.070 |
Why?
| | Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 20 | 0.070 |
Why?
| | Humans | 14 | 2014 | 144667 | 0.070 |
Why?
| | Logistic Models | 1 | 2013 | 2114 | 0.070 |
Why?
| | Intestinal Mucosa | 1 | 2014 | 675 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2011 | 1322 | 0.070 |
Why?
| | HIV-Associated Lipodystrophy Syndrome | 1 | 2007 | 9 | 0.070 |
Why?
| | Outpatients | 1 | 2011 | 447 | 0.070 |
Why?
| | Databases, Factual | 1 | 2013 | 1494 | 0.070 |
Why?
| | Follow-Up Studies | 2 | 2010 | 5414 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 1 | 2010 | 572 | 0.070 |
Why?
| | Basal Metabolism | 1 | 2007 | 59 | 0.060 |
Why?
| | Bacteria | 1 | 2014 | 894 | 0.060 |
Why?
| | HIV | 1 | 2008 | 248 | 0.060 |
Why?
| | Lipodystrophy | 1 | 2007 | 13 | 0.060 |
Why?
| | Body Temperature Regulation | 1 | 2007 | 107 | 0.060 |
Why?
| | Cross-Sectional Studies | 2 | 2010 | 5870 | 0.060 |
Why?
| | Risk Factors | 2 | 2011 | 10796 | 0.060 |
Why?
| | gag Gene Products, Human Immunodeficiency Virus | 1 | 2006 | 10 | 0.060 |
Why?
| | Glyburide | 1 | 2006 | 31 | 0.060 |
Why?
| | Patient Satisfaction | 1 | 2010 | 707 | 0.060 |
Why?
| | Caloric Restriction | 1 | 2007 | 126 | 0.060 |
Why?
| | Socioeconomic Factors | 1 | 2010 | 1322 | 0.060 |
Why?
| | Amino Acid Sequence | 2 | 2006 | 2136 | 0.060 |
Why?
| | Sequence Alignment | 1 | 2006 | 371 | 0.060 |
Why?
| | Molecular Sequence Data | 2 | 2006 | 2909 | 0.050 |
Why?
| | Energy Intake | 1 | 2007 | 501 | 0.050 |
Why?
| | Energy Metabolism | 2 | 2007 | 927 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2942 | 0.050 |
Why?
| | Anti-HIV Agents | 1 | 2011 | 890 | 0.050 |
Why?
| | Immunocompetence | 1 | 2004 | 46 | 0.050 |
Why?
| | Aging | 1 | 2014 | 1938 | 0.050 |
Why?
| | Retrospective Studies | 2 | 2012 | 17149 | 0.050 |
Why?
| | Treatment Outcome | 2 | 2012 | 11735 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2004 | 422 | 0.050 |
Why?
| | Metformin | 1 | 2006 | 320 | 0.050 |
Why?
| | Lung Diseases, Interstitial | 1 | 2008 | 660 | 0.040 |
Why?
| | Cohort Studies | 1 | 2011 | 5957 | 0.040 |
Why?
| | Genetic Variation | 1 | 2006 | 985 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2006 | 4110 | 0.030 |
Why?
| | Calorimetry, Indirect | 2 | 2007 | 72 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2006 | 1388 | 0.030 |
Why?
| | Antigens, CD34 | 1 | 1996 | 88 | 0.030 |
Why?
| | Laryngeal Neoplasms | 1 | 1996 | 36 | 0.030 |
Why?
| | Oncogene Proteins | 1 | 1996 | 61 | 0.030 |
Why?
| | Hyaluronan Receptors | 1 | 1996 | 104 | 0.030 |
Why?
| | Risk Assessment | 1 | 2004 | 3729 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 1996 | 691 | 0.020 |
Why?
| | Body Composition | 2 | 2007 | 689 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2004 | 1928 | 0.020 |
Why?
| | Adipose Tissue | 2 | 2007 | 643 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1996 | 532 | 0.020 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1996 | 643 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 1996 | 1319 | 0.020 |
Why?
| | Erlotinib Hydrochloride | 1 | 2008 | 72 | 0.020 |
Why?
| | Quinazolines | 1 | 2008 | 266 | 0.020 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2006 | 45 | 0.020 |
Why?
| | Postprandial Period | 1 | 2007 | 114 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2007 | 116 | 0.020 |
Why?
| | Fluorides | 1 | 2006 | 49 | 0.020 |
Why?
| | Polyurethanes | 1 | 2006 | 38 | 0.020 |
Why?
| | Methacrylates | 1 | 2006 | 119 | 0.010 |
Why?
| | Phenotype | 1 | 2014 | 3147 | 0.010 |
Why?
| | ErbB Receptors | 1 | 2008 | 632 | 0.010 |
Why?
| | Triglycerides | 1 | 2007 | 517 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2591 | 0.010 |
Why?
| | Eating | 1 | 2007 | 388 | 0.010 |
Why?
| | Prognosis | 2 | 2008 | 4312 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1301 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2008 | 1501 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 2007 | 567 | 0.010 |
Why?
| | RNA, Viral | 1 | 2006 | 689 | 0.010 |
Why?
| | Biomarkers | 1 | 2014 | 4261 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2870 | 0.010 |
Why?
| | Phylogeny | 1 | 2006 | 1024 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2008 | 971 | 0.010 |
Why?
| | Disease Progression | 1 | 2006 | 2847 | 0.010 |
Why?
| | Body Mass Index | 1 | 2007 | 2419 | 0.010 |
Why?
| | Mutation | 1 | 2008 | 4081 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 14122 | 0.010 |
Why?
| | Larynx | 1 | 1996 | 56 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1996 | 153 | 0.010 |
Why?
| | Adolescent | 1 | 2014 | 22409 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 1996 | 368 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 1996 | 1705 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 1996 | 1465 | 0.010 |
Why?
| | Gene Expression | 1 | 1996 | 1476 | 0.010 |
Why?
| | Apoptosis | 1 | 1996 | 2397 | 0.000 |
Why?
| | Prospective Studies | 1 | 1996 | 7994 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1996 | 8284 | 0.000 |
Why?
| | Aged | 1 | 1996 | 25955 | 0.000 |
Why?
|
|
Koeppe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|